Global Adam17 Deficiency Preserves Renal Function and Modulates Integrated Pathogenic Responses in Experimental...

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Diabetic kidney disease (DKD) involves complex metabolic, inflammatory, and fibrotic pathways.
• The role of global Adam17 deficiency in DKD pathogenesis is not fully understood.
• Previous studies suggested renoprotective effects of cell-specific Adam17 deletion.

Purpose of the Study:

• To investigate the impact of global Adam17 deletion on the renal response to diabetes.
• To assess renal function, structural injury, and molecular pathways in diabetic Adam17 knockout mice.

Main Methods:

• Used a streptozotocin-induced type 1 diabetes mouse model.
• Administered tamoxifen to induce global Adam17 deletion.
• Assessed renal function, histological damage, inflammation, and signaling pathways.

Main Results:

• Diabetic Adam17 knockout mice showed preserved glomerular filtration rate despite hyperglycemia and albuminuria.
• Adam17 deficiency attenuated kidney injury, mesangial expansion, and fibrotic remodeling.
• Reduced macrophage infiltration, chemokine expression, and modulated stress-related signaling pathways (e.g., PI3K/Akt).

Conclusions:

• Global Adam17 deletion confers significant protection against DKD.
• This protection is achieved by attenuating inflammatory, stress-related, and profibrotic pathways.
• Adam17 signaling represents a potential therapeutic target for managing diabetic kidney disease.